Table 4.
Pretreatment and posttreatment clinical characteristics of the impaired glucose tolerance patients with hypercholesterolemia treated with atorvastatin
| Parameters | Pretreatment (n = 32) | Posttreatment (n = 32) | P value |
|---|---|---|---|
| BMI (kg/m2) | 26.11 ± 4.57 | 26.03 ± 4.57 | 0.244 |
| SBP (mmHg) | 126.50 ± 5.17 | 125.63 ± 5.46 | 0.255 |
| DBP (mmHg) | 75.56 ± 8.07 | 73.84 ± 8.06 | 0.151 |
| TC (mmol/l) | 5.57 ± 0.88 | 4.27 ± 1.25 | <0.001 |
| HDL-C (mmol/l) | 1.34 ± 0.24 | 1.58 ± 0.78 | 0.091 |
| LDL-C (mmol/l) | 3.40 ± 0.64 | 2.37 ± 0.93 | <0.001 |
| TG (mmol/l) | 1.51 (0.98, 2.04) | 1.18 (0.81, 1.64) | 0.060 |
| FBG (mmol/l) | 6.44 ± 0.29 | 6.23 ± 0.54 | 0.078 |
| hsCRP (mg/l) | 1.84 (1.02, 3.26) | 1.36 (0.38, 2.16) | 0.002 |
| AST (U/l) | 20.34 ± 5.68 | 20.67 ± 8.76 | 0.836 |
| ALT (U/l) | 23.53 ± 9.92 | 22.41 ± 10.67 | 0.638 |
| CR (μmol/l) | 63.68 ± 14.84 | 66.04 ± 16.05 | 0.515 |
| CK (U/l) | 83.22 ± 27.81 | 86.81 ± 36.39 | 0.487 |
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglycerides, FBG fasting blood glucose, hsCRP high sensitivity C-reactive protein, AST aspartate aminotransferase, ALT alanine aminotransferase, CR creatinine, CK creatine kinase